8.30
price up icon2.85%   0.23
after-market Handel nachbörslich: 8.38 0.08 +0.96%
loading
Schlusskurs vom Vortag:
$8.07
Offen:
$8.13
24-Stunden-Volumen:
913.94K
Relative Volume:
0.98
Marktkapitalisierung:
$693.20M
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-2.872
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
-3.04%
1M Leistung:
-3.26%
6M Leistung:
-65.11%
1J Leistung:
-54.55%
1-Tages-Spanne:
Value
$7.98
$8.57
1-Wochen-Bereich:
Value
$7.65
$8.59
52-Wochen-Spanne:
Value
$7.16
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
Firmenname
Xencor Inc
Name
Telefon
626-305-5900
Name
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Name
Mitarbeiter
250
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-05
Name
Neueste SEC-Einreichungen
Name
XNCR's Discussions on Twitter

Vergleichen Sie XNCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XNCR
Xencor Inc
8.30 693.20M 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-21 Eingeleitet William Blair Outperform
2024-12-12 Eingeleitet Wells Fargo Overweight
2024-12-02 Hochstufung Piper Sandler Neutral → Overweight
2024-04-16 Bestätigt BTIG Research Buy
2024-02-28 Herabstufung Piper Sandler Overweight → Neutral
2023-05-19 Eingeleitet BofA Securities Buy
2022-12-06 Eingeleitet Cowen Outperform
2022-10-13 Hochstufung Raymond James Outperform → Strong Buy
2022-09-21 Eingeleitet JP Morgan Overweight
2022-07-06 Fortgesetzt Canaccord Genuity Buy
2022-02-11 Eingeleitet BMO Capital Markets Outperform
2022-01-21 Eingeleitet SMBC Nikko Outperform
2021-12-15 Eingeleitet H.C. Wainwright Buy
2021-10-15 Fortgesetzt BTIG Research Buy
2021-02-24 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-04 Eingeleitet Barclays Underweight
2020-02-25 Hochstufung Guggenheim Neutral → Buy
2020-01-30 Eingeleitet RBC Capital Mkts Outperform
2019-11-20 Fortgesetzt Guggenheim Neutral
2019-08-07 Herabstufung Guggenheim Buy → Neutral
2019-08-07 Herabstufung Raymond James Outperform → Mkt Perform
2019-06-13 Eingeleitet Mizuho Buy
2019-04-12 Eingeleitet Guggenheim Buy
2019-03-27 Eingeleitet Berenberg Buy
2019-03-15 Eingeleitet Raymond James Outperform
2018-09-10 Fortgesetzt BTIG Research Buy
2018-03-28 Fortgesetzt Leerink Partners Outperform
2017-03-02 Eingeleitet Instinet Neutral
2017-03-02 Bestätigt Wedbush Outperform
2016-10-04 Eingeleitet Piper Jaffray Overweight
2015-12-22 Eingeleitet Canaccord Genuity Buy
2015-08-05 Bestätigt MLV & Co Buy
2015-02-12 Bestätigt Oppenheimer Outperform
2015-01-28 Bestätigt MLV & Co Buy
2014-07-11 Eingeleitet Oppenheimer Outperform
Alle ansehen

Xencor Inc Aktie (XNCR) Neueste Nachrichten

pulisher
Jun 18, 2025

Closing Figures Unveiled: Xencor Inc (XNCR) Drop -8.18, Closes at 8.31 - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Rhumbline Advisers Has $1.74 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

Xencor (NASDAQ:XNCR) Shares Down 5.7% on Insider Selling - Defense World

Jun 18, 2025
pulisher
Jun 18, 2025

(XNCR) On The My Stocks Page - news.stocktradersdaily.com

Jun 18, 2025
pulisher
Jun 16, 2025

Xencor director Montgomery sells shares worth $20,422 - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Xencor director Gustafson sells shares worth $27,595 - Investing.com

Jun 16, 2025
pulisher
Jun 13, 2025

Xencor Holds Annual Stockholders Meeting on June 12 - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

Xencor (NASDAQ:XNCR) Trading Up 6.3%Should You Buy? - MarketBeat

Jun 13, 2025
pulisher
Jun 12, 2025

USPTO Tells Fed. Circ. Not To Review Ruling In Xencor Case - Law360

Jun 12, 2025
pulisher
Jun 11, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jun 11, 2025
pulisher
Jun 10, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Bank of America Corp DE Sells 585,930 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

27,491 Shares in Xencor, Inc. (NASDAQ:XNCR) Acquired by Wellington Management Group LLP - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Xencor, Inc. (NASDAQ:XNCR) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

When (XNCR) Moves Investors should Listen - news.stocktradersdaily.com

Jun 05, 2025
pulisher
May 30, 2025

Xencor Inc (NASDAQ: XNCR) Jumps 2.45%: What Could Be On The Way Going Forward? - Stocksregister

May 30, 2025
pulisher
May 30, 2025

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Biotechnology Innovator with 264.58% Potential Upside - DirectorsTalk Interviews

May 30, 2025
pulisher
May 28, 2025

Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress - Investing.com Nigeria

May 28, 2025
pulisher
May 28, 2025

Xencor’s SWOT analysis: biotech stock faces pivotal year amid pipeline progress By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 27, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $929,000 Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

May 27, 2025
pulisher
May 26, 2025

Where are the Opportunities in (XNCR) - news.stocktradersdaily.com

May 26, 2025
pulisher
May 26, 2025

BNP Paribas Financial Markets Purchases 3,171 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

May 26, 2025
pulisher
May 25, 2025

Xencor, Inc. (NASDAQ:XNCR) Holdings Lowered by Jane Street Group LLC - Defense World

May 25, 2025
pulisher
May 25, 2025

Deutsche Bank AG Buys 20,128 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

May 25, 2025
pulisher
May 23, 2025

Xencor, Inc. (XNCR) Stock Analysis: Exploring a Potential 266% Upside in Biotech Investments - DirectorsTalk Interviews

May 23, 2025
pulisher
May 23, 2025

Ameriprise Financial Inc. Has $6.72 Million Stake in Xencor, Inc. (NASDAQ:XNCR) - Defense World

May 23, 2025
pulisher
May 19, 2025

Life Sciences Companies Have New Avenue to Challenge Patent Applications After Federal Court Ruling - JD Supra

May 19, 2025
pulisher
May 16, 2025

Xencor, Inc. (NASDAQ:XNCR) Position Boosted by Comerica Bank - Defense World

May 16, 2025
pulisher
May 16, 2025

Xencor Inc. Reports Revenue Growth Amidst Ongoing R&D Investments - TipRanks

May 16, 2025
pulisher
May 15, 2025

Northern Trust Corp Increases Holdings in Xencor, Inc. (NASDAQ:XNCR) - Defense World

May 15, 2025
pulisher
May 14, 2025

Investor Network: Xencor, Inc. to Host Earnings Call - ACCESS Newswire

May 14, 2025
pulisher
May 14, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World

May 14, 2025
pulisher
May 13, 2025

Cancer Centers Want Fed. Circ. To Rehear Antibody IP Fight - Law360

May 13, 2025
pulisher
May 12, 2025

Leerink Partnrs Has Bearish Forecast for Xencor Q2 Earnings - Defense World

May 12, 2025
pulisher
May 12, 2025

Wedbush Comments on Xencor’s Q2 Earnings (NASDAQ:XNCR) - Defense World

May 12, 2025
pulisher
May 12, 2025

Research Analysts Set Expectations for Xencor Q2 Earnings - Defense World

May 12, 2025
pulisher
May 11, 2025

JPMorgan cuts Xencor stock price target to $20, keeps overweight rating - Investing.com Nigeria

May 11, 2025
pulisher
May 11, 2025

Q4 Earnings Forecast for Xencor Issued By William Blair - Defense World

May 11, 2025
pulisher
May 11, 2025

What is Wedbush’s Estimate for Xencor Q4 Earnings? - Defense World

May 11, 2025
pulisher
May 10, 2025

Barclays Issues Pessimistic Forecast for Xencor (NASDAQ:XNCR) Stock Price - Defense World

May 10, 2025
pulisher
May 09, 2025

Analysts Offer Insights on Healthcare Companies: Ardent Health Partners, Inc. (ARDT), Xencor (XNCR) and LivaNova (LIVN) - The Globe and Mail

May 09, 2025
pulisher
May 08, 2025

Xencor Inc earnings missed by $0.04, revenue topped estimates - Investing.com Nigeria

May 08, 2025
pulisher
May 08, 2025

Xencor (XNCR) Analyst Rating Update: Price Target Slashed by Bar - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Xencor (XNCR) Analyst Rating Update: Price Target Slashed by Barclays | XNCR Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

JPMorgan cuts Xencor stock price target to $20, keeps overweight rating By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Xencor Reports First Quarter 2025 Financial Results - BioSpace

May 08, 2025
pulisher
May 07, 2025

Xencor: Q1 Earnings Snapshot - MySA

May 07, 2025
pulisher
May 07, 2025

Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025

Finanzdaten der Xencor Inc-Aktie (XNCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Xencor Inc-Aktie (XNCR) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
GUSTAFSON KURT A
Director
Jun 16 '25
Sale
9.22
2,993
27,595
20,183
GORMAN KEVIN CHARLES
Director
Jun 16 '25
Sale
9.22
3,173
29,255
18,905
Feigal Ellen
Director
Jun 16 '25
Sale
9.22
2,993
27,595
19,183
RANIERI RICHARD J
Director
Jun 16 '25
Sale
9.22
2,993
27,595
19,183
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):